Maraviroc for previously treated patients with R5 HIV-1 infection.
New England Journal of Medicine.
Times cited: 593
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.
Times cited: 398